“Multisite, Randomized, Double-Blind, Placebo-Controlled Pilot Clinical Trial to Evaluate the Efficacy of Buspirone as a Relapse-Prevention Treatment for Cocaine Dependence”, J Clin Psychiatry, vol. 75, pp. 757-764, 2014.
, “Evaluation of Buspirone for Relapse-Prevention in Adults with Cocaine Dependence: An Efficacy Trial Conducted in the Real World”, Contemp Clin Trials, vol. 33, pp. 993-1002, 2012.
, “Design considerations for a study to evaluate the impact of smoking cessation treatment on stimulant use outcomes in stimulant-dependent individuals.”, Contemp Clin Trials, vol. 33, no. 1, pp. 197-205, 2012.
, “Multisite, randomized, double-blind, placebo-controlled pilot clinical trial to evaluate the efficacy of buspirone as a relapse-prevention treatment for cocaine dependence.”, J Clin Psychiatry, vol. 75, no. 7, pp. 757-64, 2014.
, “Design Considerations for a Study to Evaluate the Impact of Smoking Cessation Treatment on Stimulant Use Outcomes in Stimulant-Dependent Individuals”, Contemp Clin Trials, vol. 33, pp. 197-205, 2012.
, “A Multi-Site, Double-Blind, Placebo-Controlled Pilot Clinical Trial to Evaluate the Efficacy of Buspirone as a Relapse-Prevention Treatment for Cocaine Dependence”, in College on Problems of Drug Dependence Meeting, San Juan, Puerto Rico, 2014.
, “Evaluation of buspirone for relapse-prevention in adults with cocaine dependence: an efficacy trial conducted in the real world.”, Contemp Clin Trials, vol. 33, no. 5, pp. 993-1002, 2012.
, “Medication treatment for opioid use disorder in expectant mothers (MOMs): Design considerations for a pragmatic randomized trial comparing extended-release and daily buprenorphine formulations.”, Contemp Clin Trials, vol. 93, p. 106014, 2020.
, “Immunogenicity and safety of different dose schedules and antigen doses of an MF59-adjuvanted H7N9 vaccine in healthy adults aged 65 years and older.”, Vaccine, vol. S0264-410X, no. 20, pp. 31504-31508, 2021.
, “Safety and Immunogenicity of a Single Low Dose or High Dose of Clade 2 Influenza A(H5N1) Inactivated Vaccine in Adults Previously Primed With Clade 1 Influenza A(H5N1) Vaccine”, J Infect Dis, vol. 212, pp. 525-530, 2015.
, “Safety and Immunogenicity of a monovalent inactivated influenza A/H5N8 virus vaccine given with and without AS03 or MF59 adjuvants in healthy adults.”, Clin Infect Dis, 2023.
, “Safety and immunological outcomes following human inoculation with nontypeable Haemophilus influenzae.”, J Infect Dis, vol. 208, no. 5, pp. 728-38, 2013.
, “Safety and Immunological Outcomes Following Human Inoculation with Nontypeable Haemophilus Influenzae”, J Infect Dis, vol. 208, pp. 728-738, 2013.
, “Economic Evaluation of a Home-Based Age-Related Macular Degeneration Monitoring System.”, JAMA Ophthalmol, vol. 135, no. 5, pp. 452-459, 2017.
, “Potential Effects of Hormone Therapy in Type 2 Idiopathic Macular Telangiectasia.”, Ophthalmic Res, vol. 60, no. 1, pp. 38-42, 2018.
, “Baricitinib versus Dexamethasone for Adults Hospitalised with COVID-19 (ACTT-4): a Randomised, Double-blind, Double Placebo-controlled Trial”, Lancet Respir Med, vol. 10, no. 9, pp. 888-899, 2022.
, “A case-control-study of risk factors for homophiles influenza Type B disease in Navajo children”, AM J Trop Med Hug, vol. 60, pp. 263-6, 1999.
, “A case-control study of risk factors for Haemophilus influenzae type B disease in Navajo children.”, Am J Trop Med Hyg, vol. 60, no. 2, pp. 263-6, 1999.
, “Treatment of Geographic Atrophy by the Topical Administration of OT-551: Results of a Phase II Clinical Trial”, Invest Ophthlmol Vis Sci, vol. 51, pp. 613-619, 2010.
, “Treatment of Geographic Atrophy with Subconjunctival Sirolimus: Results of a Phase I/II Clinical Trial”, Invest Ophthalmol Vis Sci, vol. 54, pp. 2941-2950, 2013.
, “Intravitreal Ranibizumab Therapy for Retinal Capillary Hemangioblastoma Related to von Hippel-Lindau Disease”, Ophthalmology, vol. 115, pp. 1957-1964, 2008.
, “Treatment of geographic atrophy by the topical administration of OT-551: results of a phase II clinical trial.”, Invest Ophthalmol Vis Sci, vol. 51, no. 12, pp. 6131-9, 2010.
, “Opioid, NSAID, and OTC Analgesic Medications for Dental Procedures: PEARL Network Findings.”, Compend Contin Educ Dent, vol. 37, no. 10, pp. 710-718, 2016.
, , “Intravitreal ranibizumab therapy for retinal capillary hemangioblastoma related to von Hippel-Lindau disease.”, Ophthalmology, vol. 115, no. 11, pp. 1957-64, 2008.
,